Search

everythinglearnresearchcommunity

for

Search:↓

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Hair follicles help skin immune recovery after UVB exposure.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

Targeting colon cancer stem cells might lead to better treatment results.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

CD201+ fascia progenitors are essential for wound healing and could be targeted for treating skin conditions.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Certain immune cells, when activated by specific signals, can encourage hair growth.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

CD34 marks potential stem cells in dog hair follicles.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

Targeting Vδ1+T-cells may help treat alopecia areata.

Gamma/delta T cells help defend skin against heavy metals.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.